Kintor Pharmaceutical Limited (KNTPF)
USD 0.16
(0.0%)
USD 0.16
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.05 Billion CNY | -13.76% |
| 2022 | -928.09 Million CNY | -11.85% |
| 2021 | -829.09 Million CNY | -65.58% |
| 2020 | -501.11 Million CNY | -121.64% |
| 2019 | -226.09 Million CNY | -119.29% |
| 2018 | -102.17 Million CNY | -129.14% |
| 2017 | -44.99 Million CNY | 22.97% |
| 2016 | -58.41 Million CNY | -339.25% |
| 2015 | -13.29 Million CNY | -40.02% |
| 2014 | -9.49 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -4505.37 USD | 96.14% |
| 2024 Q2 | -4476.29 USD | 99.9% |
| 2023 FY | - CNY | -13.76% |
| 2023 Q3 | -57.97 Thousand USD | 99.81% |
| 2023 Q1 | -15.23 Thousand USD | 99.98% |
| 2023 Q2 | -30.99 Million USD | -203261.09% |
| 2023 Q4 | -116.65 Million USD | -201123.8% |
| 2022 Q4 | -62.27 Million USD | 0.0% |
| 2022 FY | - CNY | -11.85% |
| 2022 Q2 | -81.32 Million USD | 0.0% |
| 2021 Q4 | -78.77 Million USD | 0.0% |
| 2021 FY | - CNY | -65.58% |
| 2021 Q2 | -51.51 Million USD | 0.0% |
| 2020 Q4 | -31.52 Million USD | 0.0% |
| 2020 FY | - CNY | -121.64% |
| 2020 Q2 | -24.71 Million USD | 0.0% |
| 2019 Q2 | -14.62 Million USD | 0.0% |
| 2019 Q4 | -20.43 Million USD | 0.0% |
| 2019 FY | - CNY | -119.29% |
| 2018 FY | - CNY | -129.14% |
| 2017 FY | - CNY | 22.97% |
| 2016 FY | - CNY | -339.25% |
| 2015 FY | - CNY | -40.02% |
| 2014 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | -1386.318% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -17708.015% |
| SQZ Biotechnologies Company | -64.14 Million USD | -1546.094% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -5978.417% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 1222.758% |
| Mesoblast Limited | -62.38 Million USD | -1592.299% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -68636.154% |
| Genus plc | 73.7 Million USD | 1532.593% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -15869.421% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -29666.608% |
| Marizyme, Inc. | -34.28 Million USD | -2979.859% |
| ContraFect Corporation | -64.99 Million USD | -1524.365% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -11936.263% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -23226.9% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -75218.517% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -39825.951% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -45334.715% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -203708.349% |
| Accustem Sciences Inc. | -3.74 Million USD | -28082.139% |
| RVL Pharmaceuticals plc | -48.22 Million USD | -2089.274% |
| EV Biologics, Inc. | -1.26 Million USD | -83223.679% |
| Q BioMed Inc. | -617.62 Thousand USD | -170847.723% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 29658.259% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -166853.033% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -46116.944% |
| Biomind Labs Inc. | -1.03 Million USD | -101956.162% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 10789.693% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -14643.478% |
| Skye Bioscience, Inc. | -13.54 Million USD | -7693.446% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -70883.762% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -4223184.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -27081.617% |
| IMV Inc. | -35.52 Million USD | -2872.185% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -6553.047% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -42099.722% |
| GB Sciences, Inc. | -1.41 Million USD | -74259.614% |
| Alpha Cognition Inc. | -9.7 Million USD | -10778.471% |
| HST Global, Inc. | -5303.00 USD | -19909781.199% |
| CSL Limited | 4.78 Billion USD | 122.047% |
| Halberd Corporation | -74.27 Thousand USD | -1421325.975% |
| Enzolytics Inc. | -2.12 Million USD | -49655.258% |
| Resverlogix Corp. | -11.74 Million USD | -8891.833% |
| Affymax, Inc. | -14.29 Million USD | -7285.947% |
| SYBLEU INC | -141.57 Thousand USD | -745689.039% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -34369.98% |
| argenx SE | -216.02 Million USD | -388.754% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | -1807.915% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 86856.039% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -70339.44% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 278795.452% |
| AVAX Technologies, Inc. | -6.11 Million USD | -17172.741% |
| Zenith Capital Corp. | -8.6 Million USD | -12168.429% |
| Genscript Biotech Corporation | -248.71 Million USD | -324.503% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -6060522.238% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -43057.075% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -599715.276% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | -2563.735% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -36404.218% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -100808.811% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 15702375.431% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -60232.663% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -54864.598% |
| BioStem Technologies, Inc. | -7.55 Million USD | -13877.636% |
| ONE Bio Corp. | 13.61 Million USD | 7855.951% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -582943.051% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -51228.196% |
| Agentix Corp. | -1.37 Million USD | -76868.572% |
| LadRx Corporation | 412.28 Thousand USD | 256191.326% |
| Cell Source, Inc. | -4.27 Million USD | -24611.868% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -287416.509% |
| Regen BioPharma, Inc. | 1.46 Million USD | 72122.694% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -112587.137% |
| NovAccess Global Inc. | -1.03 Million USD | -101931.703% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 12025.059% |
| Itoco Inc. | -1.86 Million USD | -56391.376% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -278025.757% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -94507.616% |
| Kadimastem Ltd | -2.62 Million USD | -40131.239% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -441389.024% |
| CytoDyn Inc. | -18.02 Million USD | -5756.237% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -1335891.851% |
| Mobile Lads Corp. | -2.24 Million USD | -47010.491% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -8633647.649% |
| Qrons Inc. | -40.08 Thousand USD | -2634118.208% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -217291.152% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 200281.066% |
| Rebus Holdings, Inc. | -951 Thousand USD | -110922.187% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -99317.237% |
| International Stem Cell Corporation | 202 Thousand USD | 522783.663% |
| Bioxytran, Inc. | -3.82 Million USD | -27538.23% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -2005638.982% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -42785.872% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | -2843.547% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -2346168.889% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -38461.76% |
| Neutra Corp. | -181.24 Thousand USD | -582431.573% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -5137.467% |
| PureTech Health plc | -11.62 Million USD | -8980.769% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -5137.826% |
| IXICO plc | -707 Thousand USD | -149238.19% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -13638.725% |
| Gelesis Holdings, Inc. | -48.34 Million USD | -2083.885% |
| CSL Limited | 4.73 Billion USD | 122.308% |
| Cellectis S.A. | -92.63 Million USD | -1039.752% |